Rapid Micro Biosystems, Inc.
RPID- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0001380106
No open-market purchases or sales by Rapid Micro Biosystems, Inc. insiders were filed in the last 90 days; 34 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Rapid Micro Biosystems, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −1 vs. Q2 2024
- Shares held
- 17.6M
- −302.1K (−1.7%) vs. Q2 2024
- Total value
- $15.6M
- +$3.84M (+32.6%) vs. Q2 2024
- New holders
- 3
- 2 more added
- Sold out
- 4
- 6 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RPID on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 34 | $30.3M |
| Q1 2026 | 46 | $36.0M |
| Q4 2025 | 42 | $42.5M |
| Q3 2025 | 29 | $49.5M |
| Q2 2025 | 29 | $52.3M |
| Q1 2025 | 28 | $40.4M |
| Q4 2024 | 19 | $10.8M |
| Q3 2024 | 19 | $15.6M |
| Q2 2024 | 21 | $12.2M |
| Q1 2024 | 23 | $18.2M |
| Q4 2023 | 26 | $14.9M |
| Q3 2023 | 23 | $23.2M |
| Q2 2023 | 24 | $21.9M |
| Q1 2023 | 31 | $29.9M |
| Q4 2022 | 42 | $27.7M |
| Q3 2022 | 53 | $82.8M |
| Q2 2022 | 52 | $112.2M |
| Q1 2022 | 59 | $181.0M |
| Q4 2021 | 55 | $227.9M |
| Q3 2021 | 49 | $401.4M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Rapid Micro Biosystems, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,434,560 | $7.51M | 0.78% | 00.0% | Unchanged |
| Kennedy Lewis Management LP | 4,939,931 | $4.40M | 20.10% | 00.0% | Unchanged |
| ABG-WTT Global Life Science Capital Partners GP Ltd | 1,038,296 | $924.1K | 4.59% | 00.0% | Unchanged |
| Vanguard Group Inc | 726,560 | $646.6K | 0.00% | −1,924−0.3% | Reduced |
| Advent International Corp | 577,777 | $514.2K | 0.01% | 00.0% | Unchanged |
| BlackRock, Inc. | 572,879 | $509.9K | 0.00% | +572,879 | New |
| Glenview Capital Management, LLC | 547,990 | $487.7K | 0.01% | −652,798−54.4% | Reduced |
| JPMorgan Chase & Co | 321,330 | $286.0K | 0.00% | −252,598−44.0% | Reduced |
| Geode Capital Management, LLC | 150,658 | $134.1K | 0.00% | −19,914−11.7% | Reduced |
| Renaissance Technologies LLC | 82,145 | $73.1K | 0.00% | +16,158+24.5% | Added |
| Millennium Management LLC | 52,184 | $46.4K | 0.00% | −6,805−11.5% | Reduced |
| Mariner, LLC | 42,000 | $37.4K | 0.00% | +42,000 | New |
| State Street Corp | 26,074 | $23.2K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 15,550 | $13.8K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 14,545 | $12.9K | 0.00% | +14,545 | New |
| Morgan Stanley | 10,108 | $9.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,607 | $4.10K | 0.00% | −3,689−44.5% | Reduced |
| Bank of America Corp | 1,680 | $1.50K | 0.00% | +1,516+924.4% | Added |
| Resources Management Corp | 500 | $0 | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −10,974−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −98−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −4−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −442−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |